PHASE-I TRIAL, PHARMACOKINETICS AND INTERFERON (IFN) INDUCTION OF AN ORAL DIVIDED-DOSE SCHEDULE OF 2-AMINO-5-BROMO-6-PHENYL-(3H)-PYRIMIDINONE (ABPP) IN CANCER-PATIENTS
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH（1985）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined